BridgeBio Pharma, Inc. (BBIO)
NASDAQ·Healthcare·Biotechnology
$69.59
-6.62%
Mkt Cap $14.77B
Analyst Ratings
Buy
16
Hold
0
Sell
0
Price Target (37 analysts)
$99.86
Range $83.00 – $157.00
Implied Upside
+43.5%
Consensus $99.86 vs current $69.59
NASDAQ·Healthcare·Biotechnology
$69.59
-6.62%
Mkt Cap $14.77B
Buy
16
Hold
0
Sell
0
Price Target (37 analysts)
$99.86
Range $83.00 – $157.00
+43.5%
Consensus $99.86 vs current $69.59